Science Current Events | Science News | Brightsurf.com
 

Vicious circle of platelets

June 01, 2016

They were published in the current issue of the renowned journal "Science Signaling". The scientists provide evidence for the first time that treatment of Alzheimer transgenic model mice with an anti-platelet drug leads to significantly reduced amyloid plaques in cerebral vessels. They together with scientists from the Research Center Jülich, Germany, identified a key mechanism for a direct involvement of platelets in the progression of the disease.

Alzheimer's disease is an age-related neurodegenerative disorder that is the most common form of senile dementia with about 35 million people worldwide who are affected by this progressive cognitive decline. By 2030, the number of Alzheimer's disease patients is predicted to increase to > 66 million people; by 2050 the number is predicted to increase already to 115 million people. Alzheimer's disease is characterized by the formation of protein agglutination, so called amyloid aggregates, and deposits of amyloid in the brain. These amyloid deposits damage structure and function of nerve tissue in the brain and lead to the loss of neuronal cells and cognitive capability.

Formation of amyloid deposits in Alzheimer's disease patients occurs not only in brain parenchyma but also in blood vessels in the brain that contributes to the severity of Alzheimer's disease pathology. The scientists from Düsseldorf already demonstrated that attachment of platelets to amyloid deposits of the vessel wall leads to ongoing platelet activation in mice. Platelets stick together and form a hemostatic plug which induced the occlusion of vessels in the brain leading to insufficient perfusion of the surrounding tissue. The current published results are predicted on the vascular form of the disease.

An involvement of platelets in Alzheimer's disease is assumed for many years. The scientists from Düsseldorf and Jülich were now able to identify the key mechanisms of a direct involvement of platelets. This mechanism is characterized by the binding of the protein amyloid-? to a specific integrin, a receptor on the platelet surface that is important for the aggregation of platelets. This binding induces the release of adenosine diphosphate (ADP) and clusterin and supports the formation of amyloid plaques. Platelets from patients with Glanzmann's thrombasthenia, a hereditary defect of platelet activation, showed no amyloid plaques in cell culture experiments.

Anti-platelet agents such as Clopidogrel are applied for the therapy and prevention of blood clots that provoke myocardial infarction and stroke. Treatment of Alzheimer transgenic mice with Clopidogrel led to reduced platelet activation, significantly reduced amyloid plaque formation and thus improved the perfusion of the brain when these mice were treated with the anti-platelet drug for three months. "Platelets directly influence the formation of amyloid deposits in cerebral vessels, and A?, in turn, activates platelets, creating a feed-forward loop that supports fibril formation in cerebral vessels of Alzheimer's disease patients" says Margitta Elvers.

If platelets have an impact on the formation of amyloid plaques in brain tissue will be investigated by the scientists of Düsseldorf University at present.

###

Original publication:

Science Signaling, Donner et al., 2016, Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ33-induced outside-in signaling and clusterin release

Heinrich-Heine University Duesseldorf


Related Amyloid Plaques Current Events and Amyloid Plaques News Articles


Human amyloid-beta acts as natural antibiotic in the brains of animal models
A new study from Massachusetts General Hospital (MGH) investigators provides additional evidence that amyloid-beta protein - which is deposited in the form of beta-amyloid plaques in the brains of patients with Alzheimer's disease - is a normal part of the innate immune system, the body's first-line defense against infection.

PET imaging with special tracer can detect and diagnose early Alzheimer's disease
The effort to find ways to detect and diagnose preclinical Alzheimer's disease (AD) has taken a big step forward with the use of positron emission tomography (PET), a "nuclear medicine" for imaging processes in the body, when PET is used with a special 'tracer' that binds to the amyloid plaques in the brain that are a characteristic cause of AD.

Study: Regular exercise at any age might stave off Alzheimer's
Recent research suggests that exercise might provide some measure of protection from Alzheimer's disease and other dementias.

New study suggests rethink of dementia causes
University of Adelaide researchers have developed a new theory for the causes of dementia and other neurodegenerative diseases, involving an out-of-control immune system.

PET scans reveal that tau predicts Alzheimer's disease progression
Thanks to positron emission tomography (PET) imaging of tau, which has only recently become available, researchers now report that tau tangles provide a good indication of cognitive decline in later stages of the disease.

Body's immune system may play larger role in Alzheimer's disease than thought
Immune cells that normally help us fight off bacterial and viral infections may play a far greater role in Alzheimer's disease than originally thought, according to University of California, Irvine neurobiologists with the Sue & Bill Gross Stem Cell Research Center and the Institute for Memory Impairments and Neurological Disorders.

Head injury patients develop brain clumps associated with Alzheimer's disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.

Fishing for answers about mercury consumption
It's a fishy situation: On the one hand, multiple scientific studies have found that eating seafood helps protect against dementia. On the other hand (or fin), seafood also is a source of the element mercury, which has been thought to cause damage to cells in the brain, contributing to cognitive impairment.

Magnesium ions show promise in slowing progression of Alzheimer's disease in mice
New research published in the December 2015 issue of The FASEB Journal, shows that in mouse models of the disease oral administration of magnesium-L-threonate (MgT) alleviated cognitive decline by suppressing the Aβ deposition in amyloid plaques in an APH-1α/1β-dependent manner.

Neuroscientists gain insight into cause of Alzheimer's symptoms
Virginia Tech Carilion Research Institute scientists have uncovered a mechanism in the brain that could account for some of the neural degeneration and memory loss in people with Alzheimer's disease.
More Amyloid Plaques Current Events and Amyloid Plaques News Articles

Intracellular Consequences of Amyloid in Alzheimer's Disease

Intracellular Consequences of Amyloid in Alzheimer's Disease
by Michael R. D'Andrea (Author)


Consequences of Intracellular Amyloid in Alzheimer’s Disease addresses one of the more currently unresolved aspects confounding Alzheimer’s research, the significance of intraneuronal amyloid. It seeks to explain some of the unresolved questions concerning intracellular amyloid and its origin, entry, and toxicity. Following up on Dr. D’Andrea’s first book, Bursting Neurons and Fading Memories: An Alternative Hypothesis for the Pathogenesis of Alzheimer’s Disease, this book further examines the Inside-Out or Bursting alternative hypothesis of how amyloid escapes the circulatory system to ultimately enter neurons, also examining whether there is a relationship between intracellular amyloid, amyloid plaques, and cognitive impairment. Through a comprehensive explanation of the...

Diet and Nutrition in Dementia and Cognitive Decline

Diet and Nutrition in Dementia and Cognitive Decline
by Colin R. Martin RN BSc MSc PhD MBA YCAP FHEA C.Psychol AFBPsS C.Sci (Editor), Victor R. Preedy (Editor)


Diet and Nutrition in Dementia and Cognitive Decline offers researchers and clinicians a single authoritative source which outlines the complex interrelationships between cognitive decline, dementia and the way diet can be modified to improve outcomes. In a cross-disciplinary field like dementia research and practice, clinicians and researchers need a comprehensive resource which will quickly help them identify a range of nutritional components and how they affect cognitive decline and the development of dementia. While the focus is on clinical applications, the book also features landmark and innovative preclinical studies that have served as the foundation of rigorous trials. Chapters explore the evidence of how nutritional components, either in the diet or supplements, can either...

Bursting Neurons and Fading Memories: An Alternative Hypothesis of the Pathogenesis of Alzheimer’s Disease

Bursting Neurons and Fading Memories: An Alternative Hypothesis of the Pathogenesis of Alzheimer’s Disease
by Michael R. D'Andrea (Author)


Advances in Alzheimer’s disease (AD) research have been challenging and without major breakthroughs in understanding its pathological basis. The reigning hypothesis suggests AD is the result of extracellular amyloid deposition that seed to form amyloid plaques, which then grow and kill neighboring neurons. However, there are several inconsistencies with this hypothesis, not to mention the inability to show clinical benefit in several failed clinical trials by pharmaceuticals (i.e., from Pfizer, Eli Lilly, etc.), and it is in the field’s best interest to explore and test multiple hypotheses for pathology rather than drive the majority of research on this single amyloid theory. Reviewing many scientifically peer-reviewed publications, this book describes the "Inside-Out" hypothesis on...

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
by Adeboye Adejare (Editor)


Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease examines the drug discovery process for neurodegenerative diseases by focusing specifically on Alzheimer’s Disease and illustrating the paradigm necessary to ensure future research and treatment success. The book explores diagnosis, epidemiology, drug discovery strategies, current therapeutics, and much more to provide a holistic approach to the discovery, development, and treatment of Alzheimer’s Disease. Through its coverage of the latest research in targeted drug design, preclinical studies, and mouse and rat models, the book is a must-have resource for all pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers working in this area. It illustrates why...

Biochemistry of Collagens, Laminins and Elastin: Structure, Function and Biomarkers

Biochemistry of Collagens, Laminins and Elastin: Structure, Function and Biomarkers
by Morten Karsdal (Author)


Biochemistry of Collagens, Laminins, and Elastin: Structure, Function, and Biomarkers provides a comprehensive introduction to collagen and structural proteins. Type I collagen is one of the most abundant molecules in the body, playing essential roles in different tissues, particularly bone and skin. A key aspect of type I collagen is its post-translational modifications which are essential for correct synthesis and structural integrity of collagens, for tissue-specific functionality, as well as for application as biomarkers of different pathologies. This volume summarizes current data on key structural proteins (collagens, laminins and elastin), reviews how these molecules affect pathologies, and describes selected modifications of proteins that result in altered signaling properties of...

Fighting Alzheimer’s Disease

Fighting Alzheimer’s Disease
by Terence McCarthy (Author)


Three factors have motivated the author to write this book: his intimate 32 years experience with Alzheimer’s disease (AD) victims,  the fact that his research revealed that no single brief document exists to guide persons over 60 in developing effective strategies and measures to significantly delay the onset of AD and the fact that only about two percent of those over 60 years of age have any awareness of the life-destroying threat of Alzheimer’s. Therefore, the author has put together this comprehensive guide. Considering the explosive projected increase of AD from the current level of 5.3 million Americans to more than 10 million by 2025, there is critical need to educate those over 60 about this deadly and enormous threat and get them to adopt the strategies and measures in...

Neuroanatomy and Pathology of Sporadic Alzheimer's Disease (Advances in Anatomy, Embryology and Cell Biology)

Neuroanatomy and Pathology of Sporadic Alzheimer's Disease (Advances in Anatomy, Embryology and Cell Biology)
by Heiko Braak (Author), Kelly Del Tredici (Author)


As indicated by its title, this monograph deals chiefly with morphologically recognizable deviations from the normal anatomical condition of the human CNS. The AD-associated pathology is illustrated from its beginnings (sometimes even in childhood) to its final form, which is reached late in life. The AD process commences much earlier than the clinically recognizable phase of the disorder, and its timeline includes an extended preclinical phase. The further the pendulum swings away from the symptomatic final stages towards the early pathology, the more obvious the lesions become, although from a standpoint of severity they are more unremarkable and thus frequently overlooked during routine neuropathological assessment. For this reason, the authors deal with the hallmark lesions in the...

Molecular Pathology of Alzheimer's Disease

Molecular Pathology of Alzheimer's Disease
by Rudy Castellani (Author), George Perry (Author)


Alzheimer’s Disease is characterized pathologically by two principal hallmark lesions: the senile plaque and the neurofibrillary tangle. Since the identification of each over 100 years ago, the major protein components have been elucidated. This has led in turn to the elaboration of metabolic cascades involving amyloid-Beta production in the case of the senile plaque, and phosphorylated-tau protein in the case of the neurofibrillary tangle. The pathogenesis and histogenesis of each have been the source of extensive investigation and some controversy in recent years, as both cascades have been implicated in the pathogenesis of Alzheimer’s Disease, relied upon in the diagnostic criteria for Alzheimer’s Disease at autopsy, and targeted for therapeutic intervention. With the...

Canine and Feline Dementia: Molecular Basis, Diagnostics and Therapy

Canine and Feline Dementia: Molecular Basis, Diagnostics and Therapy
by Gary Landsberg (Editor), Aladár Maďari (Editor), Norbert Žilka (Editor)


The book deeply focuses on the epidemiology, diagnostics, therapy and molecular basis of canine and feline dementia or cognitive dysfunction syndrome. The aim is to provide a broad overview of the current knowledge on canine and feline dementia. Experiences of clinicians are appropriately linked with current scientific knowledge in a readily comprehensible form. In the first three chapters we describe the clinical pictures of canine and feline dementia, discuss the medical causes of the disease and its phenotypic variability. In the 4th chapter we introduce the dog as an appropriate animal model for human Alzheimer’s disease progression. Then we shed light on the neuropathological hallmarks of canine and feline dementia.  For the first time we touch upon the modern diagnostic...

Amyloids: Composition, Functions and Pathology (Protein Biochemistry, Synthesis, Structure and Cellular Functions: Protein Science and Engineering)

Amyloids: Composition, Functions and Pathology (Protein Biochemistry, Synthesis, Structure and Cellular Functions: Protein Science and Engineering)
by Irene P. Halcheck (Editor), Nancy R. Vernon (Editor)




© 2017 BrightSurf.com